| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Jan 23, 2025 | Jan 27, 2025 | X4 Pharmaceuticals, Inc | COO | Sell | 86.3 | +38,920 | 8.61% | ✓ | $10.1K |
| Oct 4, 2024 | Oct 8, 2024 | X4 Pharmaceuticals, Inc | COO | Sell | 91.3 | +162,950 | 56.36% | ✓ | $38.3K |
| Sep 9, 2024 | Sep 11, 2024 | X4 Pharmaceuticals, Inc | COO | Sell | 52.5 | -2,642 | -0.91% | ✓ | $1.7K |
| Mar 11, 2024 | Mar 11, 2024 | X4 Pharmaceuticals, Inc | COO | Sell | 36.3 | -15,409 | -5.02% | ✓ | $13.6K |
| Feb 12, 2024 | Feb 12, 2024 | X4 Pharmaceuticals, Inc | COO | Sell | 50.0 | -3,683 | -1.18% | ✓ | $3.7K |
| Nov 1, 2023 | Nov 3, 2023 | X4 Pharmaceuticals, Inc | COO | Sell | 23.8 | -67,695 | -17.88% | ✓ | $49.4K |
| Sep 8, 2023 | Sep 12, 2023 | X4 Pharmaceuticals, Inc | COO | Sell | 50.0 | -2,642 | -1.76% | ✓ | $3.3K |
| Jun 30, 2023 | Jul 5, 2023 | X4 Pharmaceuticals, Inc | COO | Sell | 53.8 | -464 | -0.31% | ✓ | $877 |
| Jun 23, 2023 | Jun 26, 2023 | X4 Pharmaceuticals, Inc | COO | Sell | 52.5 | -857 | -0.56% | ✓ | $1.7K |
| Jun 15, 2023 | Jun 16, 2023 | X4 Pharmaceuticals, Inc | COO | Sell | 52.5 | -857 | -0.56% | ✓ | $1.9K |
| Mar 10, 2023 | Mar 13, 2023 | X4 Pharmaceuticals, Inc | COO | Sell | 28.8 | -18,192 | -10.64% | ✓ | $15.3K |
| Feb 13, 2023 | Feb 15, 2023 | X4 Pharmaceuticals, Inc | COO | Sell | 46.3 | -4,348 | -2.48% | ✓ | $4K |